Primary Record
Latamoxef
- In stock
- 1,869 g
- Purity
- 99.5 %
- CAS
- 64952-97-2
Compound Identifiers & Properties
- CAS
- 64952-97-2
- PubChem CID
- 47499
- SMILES
- CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O
- Canonical SMILES
- CO[C@@]1(NC(=O)C(C(=O)O)c2ccc(O)cc2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CO[C@@H]21
Names & Synonyms
- Latamoxef
- moxalactam
- Lamoxactam
- Latamoxefum
- Oxa-cephem
- Festamoxin
- Moxam
- Disodium Moxalactam
- Shiomarin
- latamoxef sodium
- 1-Oxacephalosporin
- LMOX
- Latamoxef (INN)
- latamoxef disodium
- Disodium latamoxef
- 1 Oxacephalosporin
- Latamoxefum [INN-Latin]
- Latamoxef [INN:BAN]
- Latamoxef, Disodium
- 64952-97-2
- Listeria mox supplement
- Disodium, Moxalactam
- Moxalactam, Disodium
- MOXALACTAM DISODIUM
- Spectrum_000971
- Moxalactam disodium salt
- LATAMOXEF [INN]
- LATAMOXEF [JAN]
- MOXALACTAM [MI]
- Lilly 127935
- Galanthamine hydrochloride
- Prestwick0_000819
- Prestwick1_000819
- Prestwick2_000819
- RefChem:819551
- Spectrum2_001067
- Spectrum3_000510
- Spectrum4_000064
- Spectrum5_001371
- UNII-VUF6C936Z3
- VUF6C936Z3
- MOXALACTAMSUPPLEMENT
- MOXALACTAM [VANDF]
- D0O5LU
- Epitope ID:180870
- AC1L2I6O
- AC1Q41EH
- AC1Q6LO9
- LATAMOXEF [WHO-DD]
- CHEBI:599928
- C17H22ClNO3
- BSPBio_002039
- KBioGR_000587
- KBioSS_001451
- C20H20N6O9S
- CHEMBL74632
- DivK1c_000909
- SCHEMBL194012
- Sid 734787
- EINECS 265-287-9
- SPBio_001054
- SPBio_002638
- Ly127935
- DTXCID003338
- DTXSID9023338
- GTPL12031
- KBio1_000909
- KBio2_001451
- KBio2_004019
- KBio2_006587
- KBio3_001539
- J01DA18
- JWCSIUVGFCSJCK-CAVRMKNVSA-N
- NINDS_000909
- BCP12584
- CID47499
- 7002AB
- BDBM50370589
- C20-H20-N6-O9-S
- EBC-27271
- MFCD00865991
- 64952-97-2 (FREE ACID)
- DB04570
- Moxalactam Supplement, for microbiology
- IDI1_000909
- S-6059
- SMP1_000200
- AN-38734
- DA-74904
- J24.500C
- LS-98586
- SC-50884
- 6059-S
- SBI-0051450.P003
- LY 127935
- LY-127935
- NS00011558
- S6059
- 6059 S
- C07231
- D08109
- S 6059
- (6R,7R)-7-[[2-carboxy-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 79120-38-0
- 649L972
- A867780
- EN300-19651960
- Q3827439
- BRD-A08899266-304-05-0
- (6R,7R)-7-[[3-hydroxy-2-(4-hydroxyphenyl)-3-oxopropanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R-(6alpha,7alpha,7(S*)))-7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- 7beta-(2-Carboxy-2-(4-hydroxyphenyl)acetamido)-7alpha-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-1-oxa-1-dethia-3-cephem-4-carboxylic acid
- (6R,7R)-7-{[carboxy(4-hydroxyphenyl)acetyl]amino}-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-{[carboxy(4-hydroxyphenyl)acetyl]amino}-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-
- 7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid (6R-(6alpha,7alpha,7(S*)))-
- 7b-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7a-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-1-oxa-1-dethia-3-cephem-4-carboxylic acid
- 5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid,7-((carboxy(4-hydroxyphen
- (6R,7R)-7-((2-carboxy-2-(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-((1-methyltetrazol-5-yl)sulfanylmethyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- (6R,7R)-7-((CARBOXY(4-HYDROXYPHENYL)ACETYL)AMINO)-7-METHOXY-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-5-OXA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID
- (6R,7R)-7-(2-carboxy-2-(4-hydroxyphenyl)acetamido)-7-methoxy-3-(((1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[[3-hydroxy-2-(4-hydroxyphenyl)-3-oxo-propanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[2-Carboxy-2-(p-hydroxyphenyl)acetylamino]-7-methoxy-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 265-287-9
- 5-OXA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-((CARBOXY(4-HYDROXYPHENYL)ACETYL)AMINO)-7-METHOXY-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-, (6R,7R)-
- 5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7alpha,7(S*)))-
- 5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[carboxy(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, [6R-[6.alpha.,7.alpha.,7(R*)]]-
- 5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[carboxy(4-hydroxyphenyl)acetyl]amino]-7methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-
- 5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-carboxy(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,(6R,7R)-
- 5072-47-9
- 64953-12-4
- 7-beta-(2-carboxy-2-(4-hydroxyphenyl)acetamido)-7-alpha-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-1-oxa-1-dethia-3-cephem-4-carboxylic acid